Study on Sequential Immunization of Inactivated SARS-CoV-2 Vaccine and Recombinant SARS-CoV-2 Vaccine (Ad5 Vector)
Clinical trial NCT04892459 · COMPLETED
Trial details
- NCT number
- NCT04892459
- Sponsor
- Jiangsu Province Centers for Disease Control and Prevention
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-25
- Primary completion
- 2021-07-25
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.